目的探讨丙型肝炎病毒（HCV）核心抗原酶联免疫诊断试剂检测早期HCV感染“窗口期”样本的可行性。
Objective To evaluate the performances of HCV core antigen(HCV-cAg)testing in comparison to HCV RNA and Anti-HCV detection during the preseroconversion period.
对重组乙型肝炎（乙肝） 病毒前S1抗原（1- 42 ）及核心抗原（1- 144 ）表达的融合蛋白CS1进行了免疫原性的研究分析，以便为探索HBV治疗性疫苗的研制提供实验依据。
The aim of this study was to express a fusion protein of HBV preS1 Ag(1-42) and HBcAg(1-144) and analyze its immunogenicity for further study of HBV therapeutic vaccine.
对重组乙型肝炎（乙肝） 病毒前S1抗原（1- 42 ）及核心抗原（1- 144 ）表达的融合蛋白CS1进行了免疫原性的研究分析，以便为探索HBV治疗性疫苗的研制提供实验依据。
The aim of this study was to express a fusion protein of HBV preS1 Ag(1-42) and HBcAg(1-144) and analyze its immunogenicity for further study of HBV therapeutic vaccine.
应用推荐